Primary health care policy and vision for community pharmacy and pharmacists in Jordan
Open Access
- 16 October 2020
- journal article
- research article
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 18 (4) , 2184
Abstract
Jordan is considered a low middle-income country with a population of 9.956 million in 2018. It is considered the training center for healthcare professions in the region, as the Jordanian healthcare sector has seen remarkable development. In 2017, the expenditure on health as a percentage of Gross Domestic Product (GDP) was estimated to be around 8%. The healthcare sector is divided into two main sectors; the public and the private sector with both including hospitals, primary care clinics and pharmacies. The Jordanian government has a strong commitment to health and educational programs; hence, an increase in the number of pharmacy schools and pharmacy graduates has occurred in the past few years. Health authorities, such as the Jordan Food and Drug Association (JFDA) and the Jordan Pharmaceutical Association (JPA) have played an important role in ensuring the availability and affordability of medications, and has influenced the practice of pharmacists. Protecting the pharmaceutical market and professional interests, preserving pharmacists' rights, building needed cooperation with the internal federation, and maintaining professional ethics are some of the objectives for the JPA. Hence, the integration of community pharmacists into the primary healthcare system is considered vital to the different health authorities in Jordan, emphasizing the fact that community pharmacists are the most trusted, accessible, and affordable healthcare providers in the country. There have been many developments in the pharmacy practice in the past recent years, including the establishment of ‘Good Pharmacy Practice’, new curricular development based on the international accreditation (the ACPE), a new immunization program, and health services research aimed to save patients’ lives, influence expenses, and improve patients’ quality of life. Although these developments in pharmacy practice are promising, challenges continue to exist, specifically the establishment of an evidence base for pharmaceutical care services such as the medication management review service.Keywords
This publication has 13 references indexed in Scilit:
- Cost‐benefit analysis of clinical pharmacist intervention in preventing adverse drug events in the general chronic diseases outpatientsJournal of Evaluation in Clinical Practice, 2019
- Community pharmacy ethical practice in Jordan: assessing attitude, needs and barriersPharmacy Practice, 2019
- Pharmacists in humanitarian crisis settings: Assessing the impact of pharmacist-delivered home medication management review service to Syrian refugees in JordanResearch in Social and Administrative Pharmacy, 2019
- Pharmaceutical care in community pharmacies in Jordan: a public surveyPharmacy Practice, 2018
- Health Care and Pharmacy Practice in JordanThe Canadian Journal of Hospital Pharmacy, 2017
- A conceptual framework toward identifying and analyzing challenges to the advancement of pharmacyResearch in Social and Administrative Pharmacy, 2017
- Hospital pharmacy medication reconciliation practice in Jordan: perceptions and barriersJournal of Evaluation in Clinical Practice, 2016
- Home medication management review in outpatients with chronic diseases in Jordan: a randomized control trialInternational Journal of Clinical Pharmacy, 2016
- Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers?International Journal of Pharmacy Practice, 2011
- Societal perspectives on the role of community pharmacists and over-the-counter drugs in JordanPharmacy World & Science, 2008